发明名称 Ophthalmic compositions and methods for treating ophthalmic conditions
摘要 Compositions, and methods of using such compositions, useful for placement, for example injection, into the interior of human or animal eyes are provided. Such compositions include a therapeutic component, such as one or more corticosteroids, a biocompatible polymeric component, and a solvent component. The composition is in a fluid form before placement in the interior of an eye, and becomes less fluid after the composition is placed in the eye to form an extended or delayed release drug delivery element or system. The drug delivery element is formed by the dissipation of the solvent from the composition when the composition is placed in the interior of an eye. One example of a composition includes triamcinolone acetonide as a therapeutic agent. A method of treating an ophthalmic condition, or otherwise improving or enhancing vision of a patient, comprises placing the fluid composition in the interior of the eye. The method may be practiced by injecting the fluid composition into the interior of the eye.
申请公布号 US2006009498(A1) 申请公布日期 2006.01.12
申请号 US20050180752 申请日期 2005.07.11
申请人 ALLERGAN, INC. 发明人 WHITCUP SCOTT M.
分类号 A61K31/44 主分类号 A61K31/44
代理机构 代理人
主权项
地址